2,3-disubstituted piperidine orexin receptor antagonists

Details for Australian Patent Application No. 2009307920 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Cox, Christopher D.; Flores, Broc; Schreier, John D.

Agent Spruson & Ferguson

Pub. Number AU-A-2009307920

PCT Pub. Number WO2010/048016

Priority 61/196,905 21.10.08 US

Filing date 15 October 2009

Wipo publication date 29 April 2010

International Classifications

C07D 405/00 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/048016 Priority application(s): WO2010/048016

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009307921-Disubstituted azepan orexin receptor antagonists

2009307919-Methods of forming sheeting with composite images that float and sheeting with composite images that float